PRCT Q1 2025 Earnings — PROCEPT BioRobotics Corporation Revenue & Financial Results | Market Cap Arena

PRCTPROCEPT BioRobotics Corporation

$1B

Q1 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$69M+55.3% YoY

Gross Profit

$44M63.9% margin

Operating Income

-$27M-39.7% margin

Net Income

-$25M-35.8% margin

EPS (Diluted)

$-0.45

QoQ Revenue Growth

+1.4%

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$19M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$519M

Total Liabilities

$130M

Stockholders' Equity

$389M

Cash & Equivalents

$316M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$69M	$45M	+55.3%
Gross Profit	$44M	$25M	+76.4%
Operating Income	-$27M	-$28M	+0.8%
Net Income	-$25M	-$26M	+4.7%

Geographic Segments

UNITED STATES

$60M87%

Outside the United States

$9M13%